Literature DB >> 9459259

The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers.

E I Eger1, D Gong, D D Koblin, T Bowland, P Ionescu, M J Laster, R B Weiskopf.   

Abstract

UNLABELLED: This study documents the differences in kinetics of 2 h (n = 7) and 4 h (n = 9) of 1.25 minimum alveolar anesthetic concentration (MAC) of desflurane (9.0%) versus (on a separate occasion) sevoflurane (3.0%), both administered in a fresh gas inflow of 2 L/min. These data are extensions of our previous 8-h (n = 7) studies of these anesthetics. By 10 min of anesthetic administration, average inspired (F(I)) and end-tidal concentration (F(A)) (F(I)/F(A); the inverse of the more commonly used F(A)/F(I)) decreased to less than 1.15 for both anesthetics, with the difference from 1.0 nearly twice as great for sevoflurane as for desflurane. During all sevoflurane administrations, F(A)/F(I) for Compound A [CH2F-O-C(=CF2) (CF3); a vinyl ether resulting from the degradation of sevoflurane by Baralyme] equaled approximately 0.8, and the average inspired concentration equaled approximately 40 ppm. Compound A is of interest because at approximately 150 ppm-h, it can induce biochemical and histological evidence of glomerular and tubular injury in rats and humans. During elimination, F(A)/F(A0) for Compound A (F(A0) is the last end-tidal concentration during anesthetic administration) decreased abruptly to 0 after 2 h and 4 h of anesthesia and to approximately 0.1 (F(A) approximately 3 ppm) after 8 h of anesthesia. In contrast, F(A)/F(A0) for desflurane and sevoflurane decreased in a conventional, multiexponential manner, the decrease being increasingly delayed with increasing duration of anesthetic administration. F(A)/F(A0) for sevoflurane exceeded that for desflurane for any given duration of anesthesia, and objective and subjective measures indicated a faster recovery with desflurane. Times (mean +/- SD) to initial response to command (2 h 10.9 +/- 1.2 vs 17.8 +/- 5.1 min, 4 h 11.3 +/- 2.1 vs 20.8 +/- 4.8 min, 8 h 14 +/- 4 vs 28 +/- 8 min) and orientation (2 h 12.7 +/- 1.6 vs 21.2 +/- 4.6 min, 4 h 14.8 +/- 3.1 vs 25.3 +/- 6.5 min, 8 h 19 +/- 4 vs 33 +/- 9 min) were shorter with desflurane. Recovery as defined by the digit symbol substitution test, P-deletion test, and Trieger test results was more rapid with desflurane. The incidence of vomiting was greater with sevoflurane after 8 h of anesthesia but not after shorter durations. We conclude that for each anesthetic duration, F(I) more closely approximates F(A) with desflurane during anesthetic administration, F(A)/F(A0) decreases more rapidly after anesthesia with desflurane, and objective measures indicate more rapid recovery with desflurane. Finally, it seems that after 2-h and 4-h administrations, all Compound A taken up is bound within the body. IMPLICATIONS: Regardless of the duration of anesthesia, elimination is faster and recovery is quicker for the inhaled anesthetic desflurane than for the inhaled anesthetic sevoflurane. The toxic degradation product of sevoflurane, Compound A, seems to bind irreversibly to proteins in the body.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459259     DOI: 10.1097/00000539-199802000-00037

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 2.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 3.  Clinical and economic factors important to anaesthetic choice for day-case surgery.

Authors:  E I Eger; P F White; M S Bogetz
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

4.  Context-sensitive decrement times for inhaled anesthetics in obese patients explored with Gas Man®.

Authors:  Jonas Weber; Johannes Schmidt; Steffen Wirth; Stefan Schumann; James H Philip; Leopold H J Eberhart
Journal:  J Clin Monit Comput       Date:  2020-02-17       Impact factor: 2.502

Review 5.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

6.  Anesthetic requirement is increased in redheads.

Authors:  Edwin B Liem; Chun-Ming Lin; Mohammad-Irfan Suleman; Anthony G Doufas; Ronald G Gregg; Jacqueline M Veauthier; Gary Loyd; Daniel I Sessler
Journal:  Anesthesiology       Date:  2004-08       Impact factor: 7.892

7.  Comparison of maintenance and emergence characteristics after desflurane or sevoflurane in outpatient anaesthesia.

Authors:  Ravi Jindal; Ved Prakash Kumra; Krishan Kumar Narani; Jayashree Sood
Journal:  Indian J Anaesth       Date:  2011-01

8.  Effect of charcoal filter on the emergence from sevoflurane anesthesia in a semi-closed rebreathing circuit.

Authors:  Dong Jin Chang; Seung Ho Choi; Yong Suk Choi; Kyeong Tae Min
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

9.  Hemodynamics and early recovery characteristics of desflurane versus sevoflurane in bariatric surgery.

Authors:  Amandeep Kaur; Anil Kumar Jain; Raminder Sehgal; Jayashree Sood
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01

10.  A randomized prospective study of desflurane versus isoflurane in minimal flow anesthesia using "equilibration time" as the change-over point to minimal flow.

Authors:  Tanuja Mallik; S Aneja; R Tope; V Muralidhar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.